Approval · Notice of Compliance 24192 · 2020
GLEOLAN: Notice of Compliance 24192
Issued September 9, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24192
- Date
- September 9, 2020
- Company
- Medexus Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLEOLAN | 02504928 | Marketed |
Medicinal ingredients
- 5-AMINOLEVULINIC ACID 1.5 G per VIAL